Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 12, 1982 - Issue 7
16
Views
20
CrossRef citations to date
0
Altmetric
Research Article

Metabolism and excretion of the liver-protective agent (+)-catechin in experimental hepatitis

, &
Pages 405-416 | Received 08 Oct 1981, Accepted 21 May 1982, Published online: 22 Sep 2008
 

Abstract

1. Following oral administration of [U-14C](+)-catechin to rats with galactosaminehepatitis, the biliary and faecal elimination of (+)-catechin metabolites was decreased compared with that in normal animals, Renal excretion of (+)-catechin metabolites was enhanced in galactosamine-hepatitis.

2. Although the biliary metabolites were present in similar proportions in galactosamine-hepatitis animals and controls, the major urinary metabolite, 3′-O-methyl (+)-catechin sulphate, was markedly decreased whereas 3′-O-methyl (+)-catechin glucuronide was increased by over 100%.

3. The total overall excretion of 3′-O-methyl (+)-catechin conjugates in rats with galactosamine-hepatitis was similar to that in normal animals indicating that catechol-O-methyltransferase activity is not significantly depressed in galactosamine-hepatitis.

4. Clearance of radioactivity from the blood following i.v. administration of [U-14C]-(+)-catechin was prolonged in galactosamine-hepatitis.

5. Liver perfusion experiments demonstrated depressed glucuronylation of (+)-catechin metabolites in galactosamine-hepatitis, whereas in liver homogenates synthesis of glucuronide conjugates of (+)-catechin metabolites was enhanced.

6. Lung slices were able to metabolize (+)-catechin and the lung is proposed as an extrahepatic site of (+)-catechin metabolism of increased importance in galactosamine-hepatitis.

7. The effects of galactosamine-hepatitis upon the structure of the hepatocyte plasma membrane are discussed in relation to decreased biliary excretion and glucuronylation.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.